Whole-genome sequencing-based analysis of Brucella species isolated from ruminants in various regions of Türki̇ye.
Animals
Whole Genome Sequencing
Phylogeny
Brucellosis
/ microbiology
Polymorphism, Single Nucleotide
Cattle
Sheep
Genome, Bacterial
Brucella
/ genetics
Goats
Humans
Ruminants
/ microbiology
Brucella melitensis
/ genetics
Virulence
/ genetics
Anti-Bacterial Agents
/ pharmacology
Brucella abortus
/ genetics
Goat Diseases
/ microbiology
B. abortus
B. melitensis
MLST
Ruminants
Türkiye
WGS
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
30 Oct 2024
30 Oct 2024
Historique:
received:
27
04
2024
accepted:
11
09
2024
medline:
30
10
2024
pubmed:
30
10
2024
entrez:
30
10
2024
Statut:
epublish
Résumé
Brucellosis, a zoonotic disease in Türkiye, which has significant direct and indirect impacts on the healthcare system and livestock. This study, which aimed to investigate the differences among Brucella spp. isolates originating from different regions of Türkiye, for implications for public health and veterinary medicine. Twenty-one isolates from ruminants and two isolates from humans obtained from various regions of Türkiye were utilized in the study. The isolates were identified and biotyped using traditional microbiological procedures, and whole-genome sequencing (WGS) was performed. This was followed by single nucleotide polymorphism (SNP)--based phylogenetic analysis and WGS-based analysis of virulence and resistance genes. Additionally, phenotypic antimicrobial resistance and phage susceptibilities were determined. The obtained data were then compared for concordance, ensuring the validity and reliability of the results. Our study, employing culture methods, polymerase chain reaction (PCR), and WGS analyses, identified 11 Brucella melitensis (bv 3 (n = 9), one each bv 1 and bv 2) and 12 B. abortus (bv 3 (n = 11), bv 9 (n = 1)) isolates All B. abortus isolates were of bovine origin, while the B. melitensis isolates were from sheep (n = 7), goat (n = 1), ram (n = 1), and humans (n = 2). In the whole-genome SNP-based phylogenetic tree, all B. melitensis strains were found to be of the IIb subtype of genotype II associated with the Eastern Mediterranean lineage. Ten different genotypes were identified in the SNP analysis of the isolates, with a maximum SNP difference of 278 and a minimum SNP difference of 4 among these genotypes. According to the WGS-SNP-based phylogenetic tree of B. abortus isolates, they were grouped in clade C1. In the SNP analysis, where ten different genotypes were identified, the SNP difference among these genotypes was a maximum of 316 and a minimum of 6. In the in silico MLST analysis performed with WGS data, B. melitensis isolates were identified as ST8 and ST102 genotypes, while B. abortus isolates were identified as ST2 and ST3 genotypes. The dominant genotypes were ST8 for B. melitensis and ST2 for B. abortus, respectively. Virulence gene analysis conducted based on WGS data of the 23 B. abortus and B. melitensis isolates revealed 43 virulence gene-associated regions in all strains, irrespective of species, host, or isolation year. Although classical resistance-related genes were not detected by WGS-based antimicrobial resistance gene analysis, phenotypic resistance analysis revealed resistance to azithromycin, rifampin, and trimethoprim/sulfamethoxazole in B. abortus and B. melitensis isolates. Both B. melitensis and B. abortus were circulating species in animals and human. The dominant genotypes were ST8 for B. melitensis and ST2 for B. abortus, respectively. All B. melitensis strains were found to be of the IIb subtype of genotype II associated with the Eastern Mediterranean lineage, while B. abortus isolates, they were grouped in clade C1. Further, a comprehensive study with a sufficient number of isolates covering all regions of Türkiye would provide more accurate information about the current epidemiological situation in the country.
Sections du résumé
BACKGROUND
BACKGROUND
Brucellosis, a zoonotic disease in Türkiye, which has significant direct and indirect impacts on the healthcare system and livestock. This study, which aimed to investigate the differences among Brucella spp. isolates originating from different regions of Türkiye, for implications for public health and veterinary medicine.
METHOD
METHODS
Twenty-one isolates from ruminants and two isolates from humans obtained from various regions of Türkiye were utilized in the study. The isolates were identified and biotyped using traditional microbiological procedures, and whole-genome sequencing (WGS) was performed. This was followed by single nucleotide polymorphism (SNP)--based phylogenetic analysis and WGS-based analysis of virulence and resistance genes. Additionally, phenotypic antimicrobial resistance and phage susceptibilities were determined. The obtained data were then compared for concordance, ensuring the validity and reliability of the results.
RESULTS
RESULTS
Our study, employing culture methods, polymerase chain reaction (PCR), and WGS analyses, identified 11 Brucella melitensis (bv 3 (n = 9), one each bv 1 and bv 2) and 12 B. abortus (bv 3 (n = 11), bv 9 (n = 1)) isolates All B. abortus isolates were of bovine origin, while the B. melitensis isolates were from sheep (n = 7), goat (n = 1), ram (n = 1), and humans (n = 2). In the whole-genome SNP-based phylogenetic tree, all B. melitensis strains were found to be of the IIb subtype of genotype II associated with the Eastern Mediterranean lineage. Ten different genotypes were identified in the SNP analysis of the isolates, with a maximum SNP difference of 278 and a minimum SNP difference of 4 among these genotypes. According to the WGS-SNP-based phylogenetic tree of B. abortus isolates, they were grouped in clade C1. In the SNP analysis, where ten different genotypes were identified, the SNP difference among these genotypes was a maximum of 316 and a minimum of 6. In the in silico MLST analysis performed with WGS data, B. melitensis isolates were identified as ST8 and ST102 genotypes, while B. abortus isolates were identified as ST2 and ST3 genotypes. The dominant genotypes were ST8 for B. melitensis and ST2 for B. abortus, respectively. Virulence gene analysis conducted based on WGS data of the 23 B. abortus and B. melitensis isolates revealed 43 virulence gene-associated regions in all strains, irrespective of species, host, or isolation year. Although classical resistance-related genes were not detected by WGS-based antimicrobial resistance gene analysis, phenotypic resistance analysis revealed resistance to azithromycin, rifampin, and trimethoprim/sulfamethoxazole in B. abortus and B. melitensis isolates.
CONCLUSION
CONCLUSIONS
Both B. melitensis and B. abortus were circulating species in animals and human. The dominant genotypes were ST8 for B. melitensis and ST2 for B. abortus, respectively. All B. melitensis strains were found to be of the IIb subtype of genotype II associated with the Eastern Mediterranean lineage, while B. abortus isolates, they were grouped in clade C1. Further, a comprehensive study with a sufficient number of isolates covering all regions of Türkiye would provide more accurate information about the current epidemiological situation in the country.
Identifiants
pubmed: 39472798
doi: 10.1186/s12879-024-09921-w
pii: 10.1186/s12879-024-09921-w
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1220Informations de copyright
© 2024. The Author(s).
Références
Infect Dis Clin Microbiol. 2023 Dec 29;5(4):367-375
pubmed: 38633857
J Bacteriol. 2009 Apr;191(8):2864-70
pubmed: 19201792
Front Microbiol. 2023 Apr 14;14:1137932
pubmed: 37125183
BMC Genomics. 2018 May 10;19(1):353
pubmed: 29747573
Emerg Infect Dis. 2023 Sep;29(9):1789-1797
pubmed: 37610167
Emerg Infect Dis. 2016 Jan;22(1):79-82
pubmed: 26689610
Front Microbiol. 2016 Dec 21;7:2049
pubmed: 28066370
BMC Public Health. 2018 Jan 11;18(1):125
pubmed: 29325516
Transbound Emerg Dis. 2022 Nov;69(6):3952-3963
pubmed: 36383491
Infect Genet Evol. 2021 Jan;87:104635
pubmed: 33189905
Pathogens. 2021 Jun 16;10(6):
pubmed: 34208761
Prilozi. 2010;31(1):21-32
pubmed: 20703181
Vet Pathol. 2014 Nov;51(6):1076-89
pubmed: 24981716
Front Public Health. 2023 Mar 15;11:1106361
pubmed: 37006545
Comp Immunol Microbiol Infect Dis. 2023 May;96:101981
pubmed: 37043846
Microorganisms. 2021 Sep 13;9(9):
pubmed: 34576838
Mikrobiyol Bul. 2004 Jul;38(3):187-91
pubmed: 15490837
BMC Genomics. 2015 Feb 18;16:93
pubmed: 25888205
Pathogens. 2023 Jan 03;12(1):
pubmed: 36678430
J Clin Microbiol. 2011 Sep;49(9):3276-83
pubmed: 21795514
Microorganisms. 2023 Aug 11;11(8):
pubmed: 37630630
Nucleic Acids Res. 2020 Jan 8;48(D1):D517-D525
pubmed: 31665441
Vet Microbiol. 2022 Jun;269:109423
pubmed: 35462118
Front Med (Lausanne). 2021 Feb 24;8:635547
pubmed: 33718408
Lancet Infect Dis. 2006 Feb;6(2):91-9
pubmed: 16439329
Vet Med Sci. 2021 Jul;7(4):1245-1253
pubmed: 33974356
Vet Q. 2021 Dec;41(1):137-151
pubmed: 33618618
Infect Genet Evol. 2020 Jul;81:104235
pubmed: 32035245
J Microbiol Methods. 2010 Jan;80(1):112-4
pubmed: 19887090
Emerg Infect Dis. 1997 Apr-Jun;3(2):213-21
pubmed: 9204307
Rev Sci Tech. 2013 Apr;32(1):149-62
pubmed: 23837373
Vet Res. 2005 May-Jun;36(3):313-26
pubmed: 15845228
One Health. 2021 Apr 27;13:100255
pubmed: 34027005
Emerg Infect Dis. 2021 Jun;27(6):1728-1731
pubmed: 34013863
Int J Med Sci. 2013 Aug 22;10(10):1406-11
pubmed: 23983603
BMC Infect Dis. 2023 Aug 14;23(1):529
pubmed: 37580676
J Clin Microbiol. 2021 Nov 18;59(12):e0021321
pubmed: 34550809
One Health. 2023 Jan 03;16:100483
pubmed: 36632477
Infect Genet Evol. 2021 Aug;92:104865
pubmed: 33872784
Pathogens. 2021 Mar 03;10(3):
pubmed: 33802270
Clin Microbiol Rev. 2017 Oct;30(4):1015-1063
pubmed: 28855266
Eur J Med Res. 2021 Jun 16;26(1):57
pubmed: 34134763
Clin Microbiol Rev. 2015 Jul;28(3):541-63
pubmed: 25876885
Front Vet Sci. 2021 Jan 07;7:539444
pubmed: 33490123
Int J Mol Sci. 2020 Oct 20;21(20):
pubmed: 33092044
Infect Genet Evol. 2009 Sep;9(5):1010-9
pubmed: 19477301
J Vet Med Sci. 2013;75(8):1035-40
pubmed: 23545462
Transbound Emerg Dis. 2022 Sep;69(5):e1253-e1268
pubmed: 35244335
Nucleic Acids Res. 2019 Jan 8;47(D1):D687-D692
pubmed: 30395255
Infect Ecol Epidemiol. 2018 Jul 24;8(1):1500846
pubmed: 30083304
J Clin Microbiol. 2008 Oct;46(10):3484-7
pubmed: 18716225